Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 12, 16:00
520.80
-7.7 (-1.46%)
VOLUME 189,291
LIVE
NSE
Dec 12, 15:59
520.85
-8.75 (-1.65%)
VOLUME 2,669,035
Download Annual Report PDF Format 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Sun Pharmaceutical Industries

------------------- in Rs. Cr. -------------------
Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 7,523.79 7,262.46 7,882.47 2,823.77 2,329.75
Less: Excise/Sevice Tax/Other Levies 109.24 130.43 151.55 99.46 86.35
Revenue From Operations [Net] 7,414.55 7,132.03 7,730.92 2,724.31 2,243.40
Other Operating Revenues 282.91 482.43 286.27 104.48 188.74
Total Operating Revenues 7,697.46 7,614.46 8,017.19 2,828.79 2,432.14
Other Income 514.41 431.82 211.58 177.76 236.61
Total Revenue 8,211.87 8,046.28 8,228.77 3,006.55 2,668.75
EXPENSES
Cost Of Materials Consumed 2,284.52 2,019.85 2,261.11 894.62 705.79
Purchase Of Stock-In Trade 1,236.50 1,170.00 934.22 185.04 200.96
Changes In Inventories Of FG,WIP And Stock-In Trade -162.79 -68.48 318.10 -14.53 -10.53
Employee Benefit Expenses 1,486.17 1,480.51 1,486.68 279.63 234.87
Finance Costs 223.56 530.64 551.25 18.38 0.44
Depreciation And Amortisation Expenses 418.56 463.98 660.68 101.94 85.82
Other Expenses 2,757.79 3,447.56 3,575.70 1,466.96 788.37
Total Expenses 8,244.31 9,044.06 9,787.74 2,932.04 2,005.72
Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax -32.44 -997.78 -1,558.97 74.51 663.03
Exceptional Items 0.00 -70.13 0.00 -2,875.60 0.00
Profit/Loss Before Tax -32.44 -1,067.91 -1,558.97 -2,801.09 663.03
Tax Expenses-Continued Operations
Current Tax 2.51 5.45 108.00 0.00 114.98
Deferred Tax 0.00 0.00 -192.84 27.43 31.50
Total Tax Expenses 2.51 5.45 -84.84 27.43 146.48
Profit/Loss After Tax And Before ExtraOrdinary Items -34.95 -1,073.36 -1,474.13 -2,828.52 516.55
Profit/Loss From Continuing Operations -34.95 -1,073.36 -1,474.13 -2,828.52 516.55
Profit/Loss For The Period -34.95 -1,073.36 -1,474.13 -2,828.52 516.55
Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) -0.10 -4.50 -6.00 -13.70 5.00
Diluted EPS (Rs.) -0.10 -4.50 -6.00 -13.70 5.00
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 823.35 1,046.66 419.50 384.45
Indigenous Raw Materials 0.00 1,196.50 1,214.45 475.12 321.34
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0.00 77.34 77.99 52.13 52.60
Indigenous Stores And Spares 0.00 283.04 267.50 132.80 118.52
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 240.68 240.68 721.95 310.67 517.79
Tax On Dividend 7.47 7.47 146.97 52.80 88.00
Equity Dividend Rate (%) 350.00 100.00 300.00 150.00 500.00
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for sunpharmaceuticalindustries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.